Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 54, Issue 8, Pages 2701-2713Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm1015022
Keywords
-
Categories
Funding
- J-Pharma Co., Ltd. (Tokyo, Japan)
- National Center for Research Resources at the National Institutes of Health (NCRR/NIH) [5UL1RR025780]
- Grants-in-Aid for Scientific Research [21390073] Funding Source: KAKEN
Ask authors/readers for more resources
The kidneys are a vital organ in the human body. They serve several purposes including homeostatic functions such as regulating extracellular fluid volume and maintaining acid-base and electrolyte balance and are essential regarding the excretion of metabolic waste. Furthermore, the kidneys play an important role in uric acid secretion/reabsorption. Abnormalities associated with kidney transporters have been associated with various diseases, such as gout. The current study utilized Xenopus oocytes expressing human uric acid transporter 1 (hURAT1; SLC22A12) as an in vitro method to investigate novel compounds and their ability to inhibit (14)C-uric acid uptake via hURAT1. We have prepared and tested a series of 2-ethyl-benzofuran compounds and probed the hURAT1 in vitro inhibitor structure activity relationship. As compared to dimethoxy analogues, monophenols formed on the C ring showed the best in vitro inhibitory potential. Compounds with submicromolar (i.e., IC(50) < 1000 nM) inhibitors were prepared by brominating the corresponding phenols to produce compounds with potent uricosuric activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available